Cargando…

The safety and anti-tumor effect of multiple peptides-pulsed dendritic cells combined with induced specific cytotoxic T lymphocytes for patients with solid tumors

OBJECTIVE: The aim of this study was to explore the safety and efficacy of multiple peptide-pulsed autologous dendritic cells (DCs) combined with cytotoxic T lymphocytes (CTLs) in patients with cancer. METHODS: Five patients diagnosed with cancer between November 2020 and June 2021 were enrolled and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Xuan, Zhang, Zhen, Wen, Chunli, Huang, Jianmin, Yang, Shuangning, Liu, Jinyan, Geng, Huizhen, Peng, Bing, Li, Zibo, Zhang, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628471/ https://www.ncbi.nlm.nih.gov/pubmed/37942324 http://dx.doi.org/10.3389/fimmu.2023.1284334

Ejemplares similares

Immunotherapy of patient with hepatocellular carcinoma using cytotoxic T lymphocytes ex vivo activated with tumor antigen-pulsed dendritic cells
por: Wang, Ying, et al.
Publicado: (2018)

Mesenchymal Stromal Stem Cell-Derived Microvesicles Enhance Tumor Lysate Pulsed Dendritic Cell Stimulated Autologous T lymphocyte Cytotoxicity
por: Kukia, Nasim Rahmani, et al.
Publicado: (2018)

Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes
Publicado: (1995)

Solid Tumor-Targeted Infiltrating Cytotoxic T Lymphocytes Retained by a Superantigen Fusion Protein
por: Sun, Jialin, et al.
Publicado: (2011)

Antigen-Specific Polyclonal Cytotoxic T Lymphocytes Induced by Fusions of Dendritic Cells and Tumor Cells
por: Koido, Shigeo, et al.
Publicado: (2010)

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity
Publicado: (1996)

Dendritic cells loaded with killed breast cancer cells induce differentiation of tumor-specific cytotoxic T lymphocytes
por: Neidhardt-Berard, Eve-Marie, et al.
Publicado: (2004)

Combined TLR2/4-Activated Dendritic/Tumor Cell Fusions Induce Augmented Cytotoxic T Lymphocytes
por: Koido, Shigeo, et al.
Publicado: (2013)

Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors
por: Wang, Shuhang, et al.
Publicado: (2021)

Cytolytic Activity of Effector T-lymphocytes Against Hepatocellular Carcinoma is Improved by Dendritic Cells Pulsed with Pooled Tumor Antigens
por: Chieochansin, Thaweesak, et al.
Publicado: (2019)

Dendritic Cell-Based Immunotherapy for Solid Tumors()()
por: Jung, Nam-Chul, et al.
Publicado: (2018)

Eliciting cytotoxic T lymphocytes against human laryngeal cancer-derived antigens: evaluation of dendritic cells pulsed with a heat-treated tumor lysate and other antigen-loading strategies for dendritic-cell-based vaccination
por: Wei, Fan-Qin, et al.
Publicado: (2016)

Disappearance of bone metastases in chemotherapy-resistant gastric cancer treated with antigen peptide-pulsed dendritic cell-activated cytotoxic T lymphocyte immunotherapy: A case report
por: Du, Juan, et al.
Publicado: (2018)

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo
Publicado: (1996)

Natural killer cells and cytotoxic T lymphocytes are required to clear solid tumor in a patient-derived xenograft
por: Le, Duy Tri, et al.
Publicado: (2021)

Tumor Location Correlates with Clinicopathological Features and Prognosis of the Solid Pseudopapillary Neoplasm
por: Meng, Zibo, et al.
Publicado: (2018)

Heat Shock Protein–Peptide Complexes, Reconstituted In Vitro, Elicit Peptide-specific Cytotoxic T Lymphocyte Response and Tumor Immunity
por: Blachere, Nathalie E., et al.
Publicado: (1997)

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines
Publicado: (1996)

Low Distribution of TIM-3(+) Cytotoxic Tumor-Infiltrating Lymphocytes Predicts Poor Outcomes in Gastrointestinal Stromal Tumors
por: Zhuang, Chun, et al.
Publicado: (2021)

Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges
por: Zhao, Yueshui, et al.
Publicado: (2022)

Honokiol-enhanced cytotoxic T lymphocyte activity against cholangiocarcinoma cells mediated by dendritic cells pulsed with damage-associated molecular patterns
por: Jiraviriyakul, Arunya, et al.
Publicado: (2019)

HBVsvp-Pulsed Dendritic Cell Immunotherapy Induces Th1 Polarization and Hepatitis B Virus-Specific Cytotoxic T Lymphocytes Production
por: Farag, Mohamed M S, et al.
Publicado: (2020)

WT1 Pulsed Human CD141+ Dendritic Cell Vaccine Has High Potential in Solid Tumor-Targeted Immunotherapy
por: Cho, Sung Yoon, et al.
Publicado: (2023)

Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?
por: Kazemi, Mohammad Hossein, et al.
Publicado: (2022)

Systems pharmacology dissection of Epimedium targeting tumor microenvironment to enhance cytotoxic T lymphocyte responses in lung cancer
por: Huang, Chao, et al.
Publicado: (2021)

Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells
Publicado: (1987)

Editorial: Dendritic Cell-Based Immunotherapy in Solid and Haematologic Tumors
por: Dolcetti, Riccardo, et al.
Publicado: (2020)

Effect of pulsed field ablation on solid tumor cells and microenvironment
por: Wang, Yujue, et al.
Publicado: (2022)

Dendritic cells pulsed with placental gp96 promote tumor-reactive immune responses
por: Zheng, Huaguo, et al.
Publicado: (2019)

Molecular Characterization of Antigen-Peptide Pulsed Dendritic Cells: Immature Dendritic Cells Develop a Distinct Molecular Profile when Pulsed with Antigen Peptide
por: Yang, Amy X., et al.
Publicado: (2014)

Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines
Publicado: (1995)

Generation of Tumor-Specific Cytotoxic T Cells From Blood via In Vitro Expansion Using Autologous Dendritic Cells Pulsed With Neoantigen-Coupled Microbeads
por: Kiessling, Adela, et al.
Publicado: (2022)

Molecular Imaging in Tracking Tumor-Specific Cytotoxic T Lymphocytes (CTLs)
por: Liu, Zhiyi, et al.
Publicado: (2014)

Interleukin‐12 Augments the Generation of Autologous Tumor‐reactive CD8(+) Cytotoxic T Lymphocytes from Tumor‐infiltrating Lymphocytes
por: Kuge, Soichi, et al.
Publicado: (1995)

A dendritic/tumor fusion cell vaccine enhances efficacy of nanobody-based CAR-T cells against solid tumor
por: Sun, Shuyang, et al.
Publicado: (2023)

Induction of tumour-specific CD8(+) cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer
por: Santin, A D, et al.
Publicado: (2002)

Dendritic cells are accessory cells for the development of anti- trinitrophenyl cytotoxic T lymphocytes
Publicado: (1980)

The Dendritic Cell-Regulatory T Lymphocyte Crosstalk Contributes to Tumor-Induced Tolerance
por: Janikashvili, Nona, et al.
Publicado: (2011)

Correction: Dendritic cells pulsed with placental gp96 promote tumor-reactive immune responses
por: Zheng, Huaguo, et al.
Publicado: (2019)

Umbilical cord blood-derived dendritic cells loaded with BGC823 tumor antigens and DC-derived exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumor immunity in vitro and in vivo
por: Guan, Shasha, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mq7i9nre8vqhacehla2nhtu3np